Using quality risk management in the plantibody HB-01 manufacturing by transgenic tobacco Plants for vaccine production

The production of biopharmaceuticals by transgenic plants is a promising choice to achieve the multi-kilogram amount of products needed to treat many human diseases. However, this scientific field is still lacking of approved specific guidelines regarding points to consider for manufacturing and app...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mila C., Loreley, Valdes, Rodolfo, Padilla, Sigifredo, Mendoza, Otto, Gomez, Leonardo, García A., Cristina, Geada, Déborah, Ferro, Williams, Pujol, Merardo, Tamayo, Andrés, Enriquez, Gil, Álvarez, Tatiana, Sanchez, Rafael, Brito, José
Formato: Articulo
Lenguaje:Inglés
Publicado: 2010
Materias:
Farmacia
Farmacología
biopharmaceuticals; hepatitis B vaccine; plantibody; quality risk management
Biofarmaceútica
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/7922
http://www.latamjpharm.org/resumenes/29/3/LAJOP_29_3_1_9.pdf
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata

Ejemplares similares

Ejemplares similares